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Introduction
One of the most frustrating aspects of transplant surgery
is the constant cadaveric organ shortage that the patients
and practitioners have to face. For most organs but the
heart, grafts retrieved from controlled donors after circu-
latory death (DCD) are now regularly used in some Wes-
tern countries to increase the graft pools [1,2]. The
results of transplantation of controlled DCD livers or kid-
neys are confirming the interest of such a policy [3,4].
Spectacular results have been achieved in the domain of
DCD lung transplantation, in which organ quality and
long-term survival are equivalent to grafts used from
donation after brain death (DBD), without the specific
need to change current established protocols [5].
In controlled DCD donation, donor’s death is diagnosed
on the cessation of heart beating or/and of blood circula-
tion. This absence of efficient cardiac activity may be
assessed by electrocardiography, and/or by monitoring of
the cardiac function by means of arterial pulses or by inva-
sive arterial pressure monitoring. Until now, DCD heart
transplantation (HT) has not reached clinical practice
because of concerns regarding the potential deleterious
effects of warm ischemia occurring during DCD procure-
ment on heart graft functionality and viability. Even
though the first HT performed in 1967 used hearts
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Summary
Heart transplantation remains the only definite treatment option for end-stage
heart diseases. The use of hearts procured after donation after circulatory death
(DCD) could help decrease the heart graft shortage. The aim of this study was
to evaluate the potential increase in heart graft pool by developing DCD heart
transplantation. We retrospectively reviewed our local donor database from
2006 to 2011, and screened the complete controlled DCD donor population
for potential heart donors, using the same criteria as for donation after brain
death (DBD) heart transplantation. Acceptable donation warm ischemic time
(DWIT) was limited to 30 min. During this period 177 DBD and 70 DCD
were performed. From the 177 DBD, a total of 70 (39.5%) hearts were pro-
cured and transplanted. Of the 70 DCD, eight (11%) donors fulfilled the crite-
ria for heart procurement with a DWIT of under 30 min. Within the same
period, 82 patients were newly listed for heart transplantation, of which 53
were transplanted, 20 died or were unlisted, and 9 were waiting. It could be
estimated that 11% of the DCD might be heart donors, representing a 15%
increase in heart transplant activity, as well as potential reduction in the deaths
on the waiting list by 40%.
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retrieved from what would be today considered DCD [6],
DCD HT was rapidly abandoned after the definition of
brain death. As suitable DBD hearts become more and
more scarce [7], the possibility of using heart grafts
retrieved from DCD becomes again attractive and could
help to reduce the overall mortality on waiting lists. None-
theless, before DCD HT could be re-introduced, several
concerns, especially about the functionality of such grafts,
still need to be addressed. Currently, investigations are
underway in animal models with promising results [8].
Martin et al. published an intriguing article in which suc-
cessful transplantation of DCD hearts in a pig model was
achieved after 30 min of normothermic ischemia [9]. In
1992 [10] and in 1995 [11], Grundy et al. published two
interesting studies in which DCD heart transplantations
were successfully undertaken in a lamb and in a primate
model. Of equivalent importance, it is to note that such
transplantations have already been successfully been per-
formed in pediatric setting [12], thus pushing the idea for-
ward to explore this concept of DCD heart transplantation.
However, before investing in basic research and in ani-
mal models with the goal to develop a successful DCD
heart transplantation program, it is important to deter-
mine if, by numbers, DCD heart procurement might
increase the heart graft donor pool and, as a consequence,
decrease the waiting list mortality for HT candidates. The
aim of this study was therefore to determine if suitable
DCD heart grafts could have been procured and trans-
planted amongst the pool of DCD donors procured in a
group that successfully develop programs of DCD liver
and kidney transplantations.
Methods and patients
In 2002, a program of controlled DCD procurement and
transplantation was developed at the Department of
Abdominal Surgery and Transplantation of the University
of Lie`ge, Belgium [13]. The authors retrospectively
reviewed the donor data that were prospectively included
from January 2006 until December 2011 in the local
deceased donor (DD) database. Most information on
these donors were recorded according to the Eurotrans-
plant (ET) organization donation form (downloadable at
the member ET website at the address: https://mem-
bers.eurotransplant.org/cms/mediaobject.php?file=et_donor_
information_form1.pdf), including donor age, gender,
past medical history as diabetes mellitus, hypertension
and medication, cause of death, history of cardiac arrest,
need of resuscitation, length of intensive care unit (ICU)
stay, body mass index (BMI), inotrope use and dosage,
and urinary output.
During this 6-year period, 247 effective DD (mean age:
47 years, range: 0–83; gender ratio: 1.5 male/1 female)
procedures were performed, allowing procurement of 759
subsequently transplanted organs, including 70 hearts.
Among these DD, 177 (72%) were DBD and 70 (28%)
were DCD (Fig. 1).
All DCD donations were performed in a controlled
manner in the operative room (Maastricht category III)
[14]. This DCD program and its protocol were described
in previous publications [13,15,16]. In summary, a non-
transplant physician performed the withdrawal of life sup-
port in the operative room in all cases. The vast majority
of the DCD donors received intravenous heparin before
cessation of circulation. End-of-life comfort therapy may
have been administered before support withdrawal [17].
Invasive femoral arterial pressure was used to diagnose
circulatory arrest. Organ recovery started 5 min (stand-off
period) after declaration of donor’s death on circulatory
criteria, using the super rapid technique including rapid
midline laparotomy and sternotomy with inferior vena
cava decompression in the pericardium, abdominal aortic
cannulation, and thoracic aorta clamping, as described
[18]. Donation warm ischemic time (DWIT) was defined
as the time of life-support withdrawal of the donor to the
aortic perfusion with the cold preservation solution.
DWIT was divided in two separate phases, the time of
support withdrawal to circulatory arrest (withdrawal
phase), and the time between circulatory arrest to aortic
cannulation (acirculatory phase). The characteristics of
the 70 DCD donors are presented in Table 1.
To select the potential heart graft donors within the
DCD group, the authors applied the same inclusion crite-
ria as for DBD cardiac donors, with the additional criteria
that DWIT must not exceed 30 min (Table 2). This time-
frame was selected because of the fact that above-men-
tioned studies in animal models demonstrated that a
30-min DWIT might be acceptable [9–11], as well as to
Figure 1 Evolution of the deceased donor procurement activity dur-
ing the study period.
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allow for a better comparison of our results to previously
published articles [19,20]. The characteristics of these
potential DCD cardiac donors were compared with the
effective 70 DBD cardiac donors procured within the
same time period.
In addition, to estimate the rationale of the expansion
of the heart donor pool by DCD donation, the number
of patients listed for HT, the number of HT candidate
deaths while on waiting list or delisting because of clinical
deterioration or improvement, the number of HT per-
formed during the same time period, and the number of
patients on the waiting list on December 31st 2011 were
retrospectively reviewed. The mean waiting time was also
evaluated as the period between listing and transplanta-
tion or death.
Statistics
Results are expressed as mean ± SEM. Significance of dif-
ferences between groups was measured by unpaired Stu-
dent’s t-test or Fisher’s exact test, when applicable. All
analyses were executed using Instat 3.1 for Mac OS X
(GraphPad Software Inc, San Diego, CA, USA). P-values
<0.05 were considered to be statistically significant.
Results
According to the defined selection criteria for DCD heart
donation, eight potential cardiac donors were detected,
allowing a potential 11% (8/70) increase in the cardiac
graft pool. The general characteristics of the DCD popula-
tion qualifying for heart donation are summarized in
Table 3 and compared with the effective DBD heart
donors. With the exception of the use of inotrope treat-
ment, there was no basic significant difference between
these two populations. These eight potential DCD heart
donors are presented more precisely in the Table 4. They
Table 1. Baseline DCD donors’ characteristics.
Data Range
Age (years) 54.1 3–83
Female (%) 31.4
CPR (%) 54





BMI (kg/m2) 26.6 17–45
Intensive care stay (days) 6.6 1–23
Urinary output (ml/day) 2,350 900–5,940
Pressors (%) 29.5
DWIT (min) 20.2 10–35
Withdrawal phase (min) 10.6 0–25
Acirculatory phase (min) 9.4 3–20
DCD, donation after circulatory death; CPR, cardiopulmonary resusci-
tation; BMI, body mass index; DWIT, donation warm ischemic time.
Table 2. Criteria for DBD and DCD heart donation.
Standard DBD heart donation criteria




Heart rate between 60 and 120 bpm
Systolic pressure >90 mmHg
Inotropic support <10 lg/kg of dobutamine/dopamine
Inotropic support <1 lg/kg of norepinephrine
Cardiac arrest <15 min
CPR <30 min within the last 24 h
No episode of severe or prolonged hypotension
Mechanical ventilation <7 days
Additional criteria for DCD heart donation
DWIT < 30 min
Unperformed test
Coronary angiography in males >45 years and females >55 years
Cardiac echography: LVEF >45%
DBD, donation after brain death; DCD, donation after circulatory
death; CPR, cardiopulmonary resuscitation; DWIT, donation warm
ischemic time; EFLV, left ventricle ejection fraction.
Table 3. Comparison between effective DBD and potential DCD
heart donors in the study period.
Effective
DBD heart
donors (n = 70)
Potential DCD
heart donors
(n = 8) P
Age (years) 35.6 ± 1.6 35 ± 3.4 0.89
Female (%) 31.4 25 0.71
CPR (%) 10 12.5 0.89
Causes of death (%)
Anoxia 16.5 0 0.2
Trauma 65 50 0.48
CVA 18.5 37.5 0.21
Other (euthanasia) 0 12.5
BMI (kg/m2) 23.6 ± 0.5 22.9 ± 1.3 0.66
Intensive care stay (days) 3.3 ± 0.4 4.9 ± 0.6 0.19
Urinary output (ml/day) 3,817 ± 207 3,453 ± 551.6 0.58
Pressors (%) 82.8 25 0.0015
DWIT (min) NA 15.1 ± 0.5
(range: 13–17)
Withdrawal phase (min) NA 7.0 ± 0.7
(range: 3–10)
Acirculatory phase (min) NA 8.1 ± 0.6
(range: 5–10)
DBD, donation after brain death; DCD, donation after circulatory
death; CPR, cardiopulmonary resuscitation; CVA, cerebrovascular acci-
dent; BMI, body mass index; NA, not available; DWIT, donation warm
ischemic time.
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were mostly young males, without inotrope support, and
very few cardiac events.
Within the same period of 6 years, 82 patients were
listed for HT, among whom 53 were transplanted, 20 died
or were delisted (9 died/11 delisted for other reasons),
and 9 were still waiting in January 2012. The average time
patients remained on the waiting list was
157.1 ± 56.5 days. The effective transplantation of the
eight potential DCD heart grafts could have represented a
potential maximal 40% reduction in deaths on the wait-
ing list if a suitable recipient was found for all these DCD
heart grafts, and a 15% increase in HT activity.
Discussion
In this study, the authors retrospectively analyzed a sin-
gle-center donor database to identify possible DCD heart
donors over a 6-year period. Using the defined inclusion
criteria, eight potential heart donors were identified out
of 70 DCD donors. This would represent, over the ana-
lyzed time span, an increase of 11% (8/70) in heart pro-
curement activity and a potential 40% decrease in waiting
list mortality. These figures are situated in between of
those published by Singhal et al. [19] as well as by Osaki
et al. [20], which reported an increase of 6% in transplant
activity and a 15% increase in the donor pool using DCD
for heart donation, respectively.
In the 1960s, the first DD organ procurements were
performed after declaration of donor death based on car-
diocirculatory arrest criteria, and this was also the case
for the Barnard’s HT [6]. The concept of brain death was
confirmed in 1968 by the Ad Hoc Committee at Harvard
Medical School [21]. The wide acceptance of brain death
in the Western world, and the better DBD results because
of the absence of DWIT, led to the near complete DCD
abandonment, but the increasing organ donor shortage
has renewed the interest for this particular type of DD.
Two different DCD processes may be identified: uncon-
trolled DCD involves organ procurement after unexpected
cardiopulmonary arrest and/or unsuccessful resuscitation
[22]. In controlled DCD, the cardiocirculatory arrest is the
consequence of a planned medical act of withdrawal of
ventilatory and organ-perfusion support that can be per-
formed either in the ICU or in the OR. In controlled
DCD, procurement WI might be recorded and mini-
mized, as the procurement team is notified of the process
and may be ready to start the surgical organ procurement
a few minutes after declaration of death. In addition, cold
ischemia may also be minimized as the potential organ
recipients may be called in hospital before the planned
withdrawal of donor’s life support. Considering HT, con-
trolled DCD is probably the first, and maybe unique, type
of DCD to investigate.
In this study, with the exception of inotrope use, there
was no statistical basic difference between the potential
DCD heart donors and the DBD donors that actually
donated their heart. This finding can mostly be
explained by the fact that the used inclusion criteria
were identical in both groups, with the sole exception of
DWIT. It is also important to note that the sample size
is quite small, with eight patients in the potential DCD
heart group, rendering statistical analysis difficult. How-
ever, the analysis showed a statistical significant differ-
ence in the need of inotropic support between potential
DCD and effective DBD heart donors. We believe that
this observation could be explained by the effects of the
catecholamine rush associated with brain death in the
DBD group leading to myocardial dysfunction during
the time of potential donor assessment and therefore a
raised demand of inotropic drugs to maintain correct
hemodynamic parameter [23]. However, it remains to be
determined if DCD hearts could be of better quality
compared with DBD hearts, as they do not have to sus-
tain the massive DBD catecholamic rush that leads to
myocardial insult. Because of the critical nature of heart
transplantation, it would be preferable to assess the via-
bility and functionality of such grafts in an ex-vivo set-
ting before proceeding to implantation, as it is already










1 2006 F 43 Euthanasia 0 – – – 7 min 17 min
2 2006 M 43 Trauma 4 – – – 8 min 17 min
3 2010 M 44 Trauma 3 – – – 8 min 15 min
4 2010 F 29 CVA 7 0.7 lg/kg/min – – 6 min 16 min
5 2011 M 40 CVA 7 0.1 lg/kg/min – – 3 min 13 min
6 2011 M 16 Trauma 6 – 10 min 12 min 7 min 15 min
7 2011 M 28 CVA 4 – – – 6 min 13 min
8 2011 M 37 Trauma 3 – – – 10 min 15 min
COD, cause of death; DCD, donation after circulatory death; CPR, cardiopulmonary resuscitation; DWIT, donation warm ischemic time; CVA, cere-
brovascular accident.
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done to some extend in kidney [24] and lung transplan-
tation [25]. Studies determining suitable prediction
factors for the recovery of DCD hearts in an ex-vivo set-
ting have been presented and published [26]. Such pro-
tocols will constitute a cornerstone for organ
transplantation in the future, especially concerning mar-
ginal and/or DCD grafts.
Since the first HT performed by Bernard in 1967, the
criteria for heart donation have constantly evolved and
been refined becoming more and more rigorous. Com-
bined to an aging population frequently suffering from
cardiovascular diseases, this fact leads to a persistent and
continuously evolving organ shortage, combined to an
increasing demand. As shown in this article, the use of
hearts procured from DCD donors could contribute to a
real extent to address the growing demand in HT, within
a very short time span of investigation.
Beside the small numbers of potential DCD heart
donors, one of the limitations of this study is its retro-
spective nature inducing the lack of certain data points
and, as a consequence, the exclusion of some DCD
donors from this series, because the authors could not
potentially complete all inclusion criteria. In addition,
cardiac echography was not performed in this DCD
donor series, as they were not considered for potential
heart donation. In the setting of DCD HT, it is possible
that some of these donors could have been excluded for
heart donation because of an abnormal cardiac echogra-
phy or other cardiac abnormalities that the authors could
not retrospectively detect from the medical files. On the
other hand, if a clinical DCD HT program would begin,
it could be possible to somehow select potential donors
with less selective criteria, as longer intubation period or
diabetic and older patients. However, performing coro-
nary angiography in potential marginal DCD heart
donors could be a matter of ethical debate, but in our
view, this could be an acceptable decision as most
patients who may eventually become DCD donors are
already equipped with a variety of ICU vascular accesses,
and the additional access needed for evaluation can easily
be implemented in a pain-free and low-risk way in such
patients.
Our study showed that roughly 10% of DCD donors
might be potential candidates for heart donation. Even
though this number may represent a 40% reduction in
deaths on our waiting list, this is still insufficient. One
could also wonder if the use of DCD donors with
extended or enlarged criteria for heart donation can be
foreseen. However, DCD HT will require being extre-
mely selective in the early experience. The number of
potential DCD heart donors could potentially be higher
in an active program, identifying potential donors at an
early stage and therefore applying adapted donor man-
agement when withdrawal of care and organ donation is
decided.
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